Finance

Lists
Why is AVD down 6,43%?
Dive Deeper
AVD:NYSE
American Vanguard Corp
USD 1,60
-6,43%
(-0,11) 1D
USD 1,60
0,00% (0,00)
After hours
Closed: 9 Okt., 16:00:09 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVD...
Open
USD 1,71
High
USD 1,71
Low
USD 1,60
Mkt. cap
47,20 m
Avg. vol.
274,42 k
Volume
385,47 k
52-wk high
USD 5,55
52-wk low
USD 1,60
EPS
-USD 1,91
Beta
1,49
Shares outstanding
29,50 m
No. of employees
739
Open
USD 1,71
High
USD 1,71
Low
USD 1,60
Mkt. cap
47,20 m
Avg. vol.
274,42 k
Volume
385,47 k
52-wk high
USD 5,55
52-wk low
USD 1,60
EPS
-USD 1,91
Beta
1,49
Shares outstanding
29,50 m
No. of employees
739
News stories
From web sources and news partners
Profile
American Vanguard Corporation, through its subsidiary AMVAC Chemical Corporation, is an American producer of agrochemicals and pesticide delivery systems. The company was founded by Herbert A. Kraft and Glenn A. Wintemute, with the latter stepping down as president in 1994 and his son Eric Wintemute taking over as chairman and chief executive officer. The company operates factories in Los Angeles and Axis, Alabama. American Vanguard trades on the New York Stock Exchange under the ticker symbol "AVD." Products have included dichlorvos, metam sodium, mevinphos, pentachloronitrobenzene and terbufos. Wikipedia
About American Vanguard Corp
CEOEric G Wintemute
Employees739
Founded1969
HeadquartersNewport Beach, Kalifornië, Verenigde State van Amerika
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
10 Aug. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (USD)
116,75 m / 135,00 m
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
119,31 m
150,69 m
123,57 m
116,75 m
Cost of goods sold
85,10 m
108,08 m
85,15 m
82,04 m
Cost of revenue
85,10 m
108,08 m
85,15 m
82,04 m
Research and development expenses
5,65 m
6,02 m
5,27 m
6,48 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,75 m
28,64 m
27,71 m
26,62 m
Operating expense
39,43 m
37,36 m
33,06 m
33,23 m
Total operating expenses
124,53 m
145,44 m
118,22 m
115,27 m
Operating income
-5,22 m
5,25 m
5,35 m
1,49 m
Other non operating income
-
-
-
-
EBT including unusual items
-11,94 m
-27,11 m
-4,02 m
-9,48 m
EBT excluding unusual items
-10,14 m
-84,00 k
-438,00 k
-7,64 m
Income tax expense
422,00 k
1,10 m
124,00 k
383,00 k
Effective tax rate
-3,54%
-4,08%
-3,08%
-4,04%
Other operating expenses
7,03 m
2,70 m
81,00 k
119,00 k
Net income
-12,36 m
-28,21 m
-4,14 m
-9,87 m
Net profit margin
-10,36%
-18,72%
-3,35%
-8,45%
Earnings per share
-
-
-
-
Interest and investment income
-
106,00 k
2,00 k
152,00 k
Interest expense
-4,92 m
-5,44 m
-5,79 m
-9,28 m
Net interest expenses
-4,92 m
-5,34 m
-5,79 m
-9,13 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-651,00 k
9,99 m
10,04 m
5,82 m
Gain or loss from assets sale
-206,00 k
171,00 k
-
55,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme